Predicting drug loading in PLA-PEG nanoparticles

被引:44
|
作者
Meunier, M. [1 ]
Goupil, A. [2 ]
Lienard, P. [3 ]
机构
[1] Dassault Syst Biovia, 334 Milton Rd Sci Pk, Cambridge CB4 0WN, England
[2] Dassault Syst Biovia, 10 Rue Marcel Dassault, F-78140 Velizy Villacoublay, France
[3] Sanofi R&D, Pharmaceut Sci Dev, 13 Quai Jules Guesde, F-94400 Vitry Sur Seine, France
基金
欧盟地平线“2020”;
关键词
Drug delivery; Nanoparticles; Nanomedicine; Drug loading; Pharmaceutical development; Molecular dynamics; Solvation free energy; SOLUBILITY PARAMETERS; POLYMER MISCIBILITY; FORCE-FIELD; COEFFICIENTS; SIMULATION; MOLECULES; MIXTURES; DELIVERY;
D O I
10.1016/j.ijpharm.2017.04.043
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Polymer nanoparticles present advantageous physical and biopharmaceutical properties as drug delivery systems compared to conventional liquid formulations. Active pharmaceutical ingredients (APIs) are often hydrophobic, thus not soluble in conventional liquid delivery. Encapsulating the drugs in polymer nanoparticles can improve their pharmacological and bio-distribution properties, preventing rapid clearance from the bloodstream. Such nanoparticles are commonly made of non-toxic amphiphilic self assembling block copolymers where the core (poly-[D,L-lactic acid] or PLA) serves as a reservoir for the API and the external part (Poly-(Ethylene-Glycol) or PEG) serves as a stealth corona to avoid capture by macrophage. The present study aims to predict the drug affinity for PLA-PEG nanoparticles and their effective drug loading using in silico tools in order to virtually screen potential drugs for non-covalent encapsulation applications. To that end, different simulation methods such as molecular dynamics and Monte-Carlo have been used to estimate the binding of actives on model polymer surfaces. Initially, the methods and models are validated against a series of pigments molecules for which experimental data exist. The drug affinity for the core of the nanoparticles is estimated using a Monte-Carlo "docking" method. Drug miscibility in the polymer matrix, using the Hildebrand solubility parameter (delta), and the solvation free energy of the drug in the PLA polymer model is then estimated. Finally, existing published ALogP quantitative structure-property relationships (QSPR) are compared to this method. Our results demonstrate that adsorption energies modelled by docking atomistic simulations on PLA surfaces correlate well with experimental drug loadings, whereas simpler approaches based on Hildebrand solubility parameters and Flory-Huggins interaction parameters do not. More complex molecular dynamics techniques which use estimation of the solvation free energies both in PLA and in water led to satisfactory predictive models. In addition, experimental drug loadings and Log P are found to correlate well. This work can be used to improve the understanding of drug-polymer interactions, a key component to designing better delivery systems. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:157 / 166
页数:10
相关论文
共 50 条
  • [1] Defining the drug incorporation properties of PLA-PEG nanoparticles
    Govender, T
    Riley, T
    Ehtezazi, T
    Garnett, MC
    Stolnik, S
    Illum, L
    Davis, SS
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 199 (01) : 95 - 110
  • [2] Preparation and characterization of magnetic PLA-PEG composite nanoparticles for drug targeting
    Ren, Jie
    Hong, Haiyan
    Ren, Tianbin
    Teng, Xinrong
    REACTIVE & FUNCTIONAL POLYMERS, 2006, 66 (09): : 944 - 951
  • [3] Intranasal delivery of zidovudine by PLA and PLA-PEG blend nanoparticles
    Mainardes, Rubiana Mara
    Khalil, Najeh Maissar
    Daflon Gremiao, Maria Palmira
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 395 (1-2) : 266 - 271
  • [4] Core-shell structure of PLA-PEG nanoparticles used for drug delivery
    Riley, T
    Heald, CR
    Stolnik, S
    Garnett, MC
    Illum, L
    Davis, SS
    King, SM
    Heenan, RK
    Purkiss, SC
    Barlow, RJ
    Gellert, PR
    Washington, C
    LANGMUIR, 2003, 19 (20) : 8428 - 8435
  • [5] Colloidal stability and drug incorporation aspects of micellar-like PLA-PEG nanoparticles
    Riley, T.
    Govender, T.
    Stolnik, S.
    Xiong, C.D.
    Garnett, M.C.
    Illum, L.
    Davis, S.S.
    Colloids and Surfaces B: Biointerfaces, 1999, 16 (01): : 147 - 159
  • [6] Colloidal stability and drug incorporation aspects of micellar-like PLA-PEG nanoparticles
    Riley, T
    Govender, T
    Stolnik, S
    Xiong, CD
    Garnett, MC
    Illum, L
    Davis, SS
    COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) : 147 - 159
  • [7] Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration
    M. Tobío
    R. Gref
    A. Sánchez
    R. Langer
    M. J. Alonso
    Pharmaceutical Research, 1998, 15 : 270 - 275
  • [8] Insulin Extended Release from PLA-PEG Stereocomplex Nanoparticles
    Shapira-Furman, Tovi
    Domb, Abraham J.
    MACROMOLECULAR BIOSCIENCE, 2024, 24 (05)
  • [9] Encapsulation and Characterization of Bovine Serum Albumin in PLA-PEG Nanoparticles
    Taha, Murtada
    Singh, Shree R.
    Moore, Courtney
    Agee, Ronald
    Dennis, Vida A.
    NANOTECHNOLOGY 2012, VOL 3: BIO SENSORS, INSTRUMENTS, MEDICAL, ENVIRONMENT AND ENERGY, 2012, : 194 - 197
  • [10] Emerging uses of PLA-PEG copolymer in cancer drug delivery
    Mundel, Rohit
    Thakur, Tanya
    Chatterjee, Mary
    3 BIOTECH, 2022, 12 (02)